A Case Study for HLA Typing in Clinics: Reproducibility and Flowspace Alignment of NGS Reads

28/01/2015

Authors: Krisztina Rigó, György Horváth, Szilveszter Juhos, Sabine Canivet, Philippe Pellet, Abdelali Boudifa, Veronique Bertrand, Ioannis Theodorou Abstract: Long reads produced by Roche 454 sequencers are used for HLA typing for quite a while. Having long reads it is easier to determine the phase, but homopolymer errors are bringing in...

2014 – Blog Posts Of The Year

16/01/2015

It’s already the middle of January, so before the new year steadily sets in, we’d like to have a quick look back on the route we just came, not long ago. Omixon had an amazing and very successful 2014. We launched our brand new product Holotype HLA™, opened first offices in the...

Immunotherapy

07/01/2015

Cancer has become one of the biggest killers in the western world. High profile campaigns to tackle breast cancer and other common types have ensured that it is also one of the biggest businesses in modern medicine. To fight a high profile killer you need the best of cures. Immunotherapy...

Patient Stratification in Clinical Trials

01/12/2014

When carrying out clinical trials, one of the most important logistical and statistical challenges is ensuring that your data accurately reflects the population you are setting out to study. None of us has the resources to test a drug on the entire human race, but if we want to have...

Omixon Signs Letter of Intent with Pronto Diagnostics

10/11/2014

At Omixon we are working hard to expand our customer base. Our Holotype HLA kit is already making an impact on the HLA typing market, and we are regularly contacted by companies proposing to partner with us as local distributors. For example, we have recently signed a letter of intent with Pronto Diagnostics and...